The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014)

Table 10 Costs prevented per individual of the benefit cohort population

WHO region	Annual medical expenses averted per person within the benefit cohort^a	Annual wage loss prevented per person within the benefit cohort^a	Annual economic benefit per person within the benefit cohort^a	Equivalent number of days income per year^ab
AMRO	$1.75	$158.49	$160.24	31
AFRO	$0.77	$30.15	$30.92	31
EMRO	$0.62	$102.54	$103.17	34
WPRO	$1.32	$160.07	$161.39	32
SEARO	$1.91	$50.37	$52.27	36
Average	$1.52	$48.48	$50.00	33.3

AMRO Region of the Americas, AFRO African Region, EMRO Eastern Mediterranean Region, WPRO Western Pacific Region, SEARO South-East Asia Region. Costs are expressed in US$ 2014 prices
^aDoes not include reduction in costs to the health system (Additional file 2: Table S4)
^bAnnual economic benefit per person within the benefit cohort divided by the average wage estimate for that region (Table 6)

ISSN: 2049-9957